Your browser doesn't support javascript.
loading
Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
Cabrita, Rita; Lauss, Martin; Sanna, Adriana; Donia, Marco; Skaarup Larsen, Mathilde; Mitra, Shamik; Johansson, Iva; Phung, Bengt; Harbst, Katja; Vallon-Christersson, Johan; van Schoiack, Alison; Lövgren, Kristina; Warren, Sarah; Jirström, Karin; Olsson, Håkan; Pietras, Kristian; Ingvar, Christian; Isaksson, Karolin; Schadendorf, Dirk; Schmidt, Henrik; Bastholt, Lars; Carneiro, Ana; Wargo, Jennifer A; Svane, Inge Marie; Jönsson, Göran.
Afiliação
  • Cabrita R; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.
  • Lauss M; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.
  • Sanna A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.
  • Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Skaarup Larsen M; Department of Clinical Pathology, Herlev University Hospital, Herlev, Denmark.
  • Mitra S; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.
  • Johansson I; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.
  • Phung B; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.
  • Harbst K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.
  • Vallon-Christersson J; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.
  • van Schoiack A; NanoString Technologies, Seattle, WA, USA.
  • Lövgren K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.
  • Warren S; NanoString Technologies, Seattle, WA, USA.
  • Jirström K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.
  • Olsson H; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.
  • Pietras K; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University Cancer Center, Lund University, Lund, Sweden.
  • Ingvar C; Department of Surgery, Skåne University Hospital, Lund, Sweden.
  • Isaksson K; Department of Surgery, Skåne University Hospital, Lund, Sweden.
  • Schadendorf D; Department of Dermatology, University Hospital of Essen, Essen, Germany.
  • Schmidt H; Department of Oncology, Århus University Hospital, Aarhus, Denmark.
  • Bastholt L; Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Carneiro A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.
  • Wargo JA; Department of Oncology, Skåne University Hospital, Lund, Sweden.
  • Svane IM; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Jönsson G; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Nature ; 580(7801): E1, 2020 04.
Article em En | MEDLINE | ID: mdl-32238929
ABSTRACT
An Amendment to this paper has been published and can be accessed via a link at the top of the paper.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article